九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603456 九洲药业

已收盘 05-20 15:00:00

{"stockData":{"symbol":"603456","market":"SH","secType":"STK","nameCN":"九洲药业","latestPrice":16.2,"timestamp":1716188400000,"preClose":15.92,"halted":0,"volume":17947500,"delay":0,"floatShares":898000000,"shares":899000000,"eps":1.0999,"marketStatus":"已收盘","marketStatusCode":5,"change":0.28,"latestTime":"05-20 15:00:00","open":15.89,"high":16.42,"low":15.83,"amount":290000000,"amplitude":0.0371,"askPrice":16.2,"askSize":285,"bidPrice":16.19,"bidSize":298,"shortable":0,"etf":0,"ttmEps":1.0999,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716255000000},"adr":0,"adjPreClose":15.92,"symbolType":"stock","openAndCloseTimeList":[[1716168600000,1716175800000],[1716181200000,1716188400000]],"highLimit":17.51,"lowLimit":14.33,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":899485928,"pbRate":1.68,"roa":"--","roe":"2.77%","epsLYR":1.16,"committee":0.126897,"marketValue":14572000000,"floatMarketCap":14549000000,"peRate":14.728612,"changeRate":0.0176,"turnoverRate":0.02,"status":0},"requestUrl":"/m/hq/s/603456","defaultTab":"news","newsList":[{"id":"2436125443","title":"九洲药业05月20日主力资金流入1611万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2436125443","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436125443?lang=zh_cn&edition=full","pubTime":"2024-05-20 15:17","pubTimestamp":1716189470,"startTime":"0","endTime":"0","summary":"05月20日, 九洲药业股价涨1.76%，报收16.20元，成交金额2.90亿元，换手率2.00%，振幅3.71%，量比0.94。九洲药业今日主力资金净流入1611万元，连续3日净流入，上一交易日主力净流入958万元，今日环比增加68.16%。该行业中净流入前三个股分别为爱尔眼科、泰格医药、九洲药业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405201523578b1a7253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405201523578b1a7253&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436452913","title":"九洲药业：5月15日高管沙裕杰增持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2436452913","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2436452913?lang=zh_cn&edition=full","pubTime":"2024-05-17 20:04","pubTimestamp":1715947481,"startTime":"0","endTime":"0","summary":"证券之星消息，根据5月17日市场公开信息、上市公司公告及交易所披露数据整理，九洲药业最新董监高及相关人员股份变动情况：2024年5月15日公司董事,高级管理人员沙裕杰共增持公司股份1.0万股，占公司总股本为0.0011%。九洲药业近半年内的董监高及核心技术人员增减持详情如下：九洲药业的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入417.72万，融资余额增加；融券净流出2.76万，融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240517200702877464ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240517200702877464ec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435571190","title":"CRO概念盘中跳水，九洲药业跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435571190","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435571190?lang=zh_cn&edition=full","pubTime":"2024-05-15 09:40","pubTimestamp":1715737208,"startTime":"0","endTime":"0","summary":"05月15日，CRO概念盘中跳水，截至09点40分，CRO概念整体指数下跌2.01%，报385.380点。从个股上来看，该概念的成分股中，九洲药业跌1.54%，宣泰医药、南模生物、亚太药业跌幅居前。从资金上来看，截止发稿，CRO概念主力净流入为-3.50亿，其中海特生物受到资金热捧，主力净流入1242.50万；拉长时间线来看，该板块近20日主力资金净流入-35.18亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150940087a59f168&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150940087a59f168&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435271573","title":"九洲药业获融资买入0.22亿元，近三日累计买入0.85亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435271573","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435271573?lang=zh_cn&edition=full","pubTime":"2024-05-15 08:25","pubTimestamp":1715732703,"startTime":"0","endTime":"0","summary":"5月14日，沪深两融数据显示，九洲药业获融资买入额0.22亿元，居两市第348位，当日融资偿还额0.30亿元，净卖出773.39万元。最近三个交易日，10日-14日，九洲药业分别获融资买入0.14亿元、0.49亿元、0.22亿元。融券方面，当日融券卖出0.38万股，净买入3.91万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240515082700876a748b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240515082700876a748b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435591898","title":"九洲药业：\n公司控股股东及其一致行动人不存在转融通出借股票行为","url":"https://stock-news.laohu8.com/highlight/detail?id=2435591898","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435591898?lang=zh_cn&edition=full","pubTime":"2024-05-14 19:02","pubTimestamp":1715684564,"startTime":"0","endTime":"0","summary":"证券之星消息，九洲药业05月14日在投资者关系平台上答复投资者关心的问题。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400028199.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435564616","title":"九洲药业(603456.SH)两家子公司通过GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2435564616","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435564616?lang=zh_cn&edition=full","pubTime":"2024-05-14 16:44","pubTimestamp":1715676240,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九洲药业(603456.SH)公告，公司全资子公司浙江四维医药科技有限公司(简称“四维医药”)和控股子公司浙江九洲生物医药有限公司(简称“九洲生物”)分别从浙江省药品监督管理局网站获悉药品GMP符合性检查结果公告。本次涉及生产线为101车间片剂生产线，主要产品为磷酸西格列汀片。磷酸西格列汀片主要用于治疗2型糖尿病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1121059.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435536162","title":"九洲药业5月13日遭北向资金减持287.60万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435536162","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435536162?lang=zh_cn&edition=full","pubTime":"2024-05-14 09:30","pubTimestamp":1715650230,"startTime":"0","endTime":"0","summary":"5月13日，北向资金减持九洲药业287.60万股。截止当日收盘，沪股通共持有九洲药业1168.63万股，占流通股1.30%。沪股通减持金额前五个股分别为中远海控、长江电力、招商轮船、紫金矿业、工业富联。九洲药业近5个交易日下跌2.41%，沪股通累计减持266.69万股；近20个交易日下跌1.40%，沪股通累计减持4.24万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140933318b049350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140933318b049350&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435948347","title":"九洲药业：公司利用酶作为催化剂进行原料药和中间体的工艺开发和生产 不涉及人造肉的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2435948347","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2435948347?lang=zh_cn&edition=full","pubTime":"2024-05-13 17:11","pubTimestamp":1715591477,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问公司开发的高性能酶及高效酶催化工艺是否可用于人造肉产品开发生产中九洲药业（603456.SH）5月13日在投资者互动平台表示，公司利用酶作为催化剂进行原料药和中间体的工艺开发和生产，不涉及人造肉的应用文章来源：每日经济新闻原标题：九洲药业：公司利用酶作为催化剂进行原料药和中间体的工艺开发和生产，不涉及人造肉的应用","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131729428b00dc63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131729428b00dc63&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434836740","title":"九洲药业：\n公司目前不涉及细胞免疫治疗业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2434836740","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434836740?lang=zh_cn&edition=full","pubTime":"2024-05-10 18:04","pubTimestamp":1715335449,"startTime":"0","endTime":"0","summary":"证券之星消息，九洲药业05月10日在投资者关系平台上答复投资者关心的问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051000035953.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434611086","title":"AI制药新进展：谷歌推出新一代模型 产业链一览","url":"https://stock-news.laohu8.com/highlight/detail?id=2434611086","media":"腾讯自选股","top":-1,"share":"https://www.laohu8.com/m/news/2434611086?lang=zh_cn&edition=full","pubTime":"2024-05-09 08:14","pubTimestamp":1715213647,"startTime":"0","endTime":"0","summary":"美东时间周三，谷歌DeepMind发布了新一代预测蛋白质结构的AlphaFold 3模型，能够帮助科学家更精确地针对疾病机制，从而开发出更有效的治疗药物。据太平洋证券医药，AI制药内涵丰富，主要包括：数字生物学、计算机药物发现、实验室自动化、AI 辅助临床试验等。整体而言AI技术在制药领域的应用价值主要体现在缩短试验周期、节省成本、促进新事物发现、提升试验成功概率等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433717057","title":"九洲药业(603456.SH)：2023年7月公司当选浙江省合成生物产业技术联盟副理长单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2433717057","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2433717057?lang=zh_cn&edition=full","pubTime":"2024-05-08 17:12","pubTimestamp":1715159528,"startTime":"0","endTime":"0","summary":"格隆汇5月8日丨九洲药业(603456.SH)在投资者互动平台表示，公司凭借多年的新药研发和技术积累，已拥有催化、多肽、偶联等众多研发技术平台，2023年7月公司当选浙江省合成生物产业技术联盟副理长单位，公司研发团队专注于开发高性能酶，以及高效酶催化工艺，在小分子药物的生物绿色制造方面取得良好进展，比如在汀类药物工艺开发，降低成本明显，提升产品市场竞争力。同时，公司积极布局多肽药物等新形态分子生物合成领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405081712128ae82a09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405081712128ae82a09&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433323745","title":"九洲药业：目前公司枸橼酸西地那非口崩片的仿制药注册申请已被受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2433323745","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2433323745?lang=zh_cn&edition=full","pubTime":"2024-05-08 17:10","pubTimestamp":1715159421,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：公司有无伟哥药物研发，从白云山业绩中显示目前市场需求量很大九洲药业（603456.SH）5月8日在投资者互动平台表示，目前公司枸橼酸西地那非口崩片的仿制药注册申请已被受理，公司会就后续审批结果及时予以公告，请关注公司于上海证券交易所网站（www.sse.com.cn）披露的相关公告文章来源：每日经济新闻原标题：九洲药业：目前公司枸橼酸西地那非口崩片的仿制药注册申请已被受理","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050817591787e00083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050817591787e00083&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433716329","title":"九洲药业05月08日主力资金流出535万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2433716329","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433716329?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:17","pubTimestamp":1715152679,"startTime":"0","endTime":"0","summary":"05月08日, 九洲药业股价跌0.79%，报收16.36元，成交金额2.20亿元，换手率1.50%，振幅2.43%，量比0.72。九洲药业今日主力资金净流出535万元，连续5日净流出，上一交易日主力净流出670万元，今日环比减少20.15%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为77.78%，平均跌幅为1.42%。该股近5个交易日上涨4.87%，主力资金累计净流出5692万元；近20日主力资金累计净流出4039万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405081525168ae7d229&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405081525168ae7d229&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433414134","title":"九洲药业(603456.SH)累计回购389.53万股 耗资6999.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433414134","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2433414134?lang=zh_cn&edition=full","pubTime":"2024-05-06 17:16","pubTimestamp":1714986960,"startTime":"0","endTime":"0","summary":"九洲药业(603456.SH)公告，截止2024年4月30日，公司本次回购通过集中竞价交易方式累计回购股份389.53万股，已回购股份占公司总股本的比例为0.43%，成交的最高价为22.18元/股，最低价为15.11元/股，已支付的总金额为6999.36万元(不含交易费用)。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-05-06/doc-inauhwes8766737.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-05-06/doc-inauhwes8766737.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433441735","title":"九洲药业：累计回购约390万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433441735","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2433441735?lang=zh_cn&edition=full","pubTime":"2024-05-06 17:06","pubTimestamp":1714986413,"startTime":"0","endTime":"0","summary":"九洲药业（SH 603456，收盘价：16.6元）5月6日晚间发布公告称，截至2024年4月30日，公司本次回购通过集中竞价交易方式累计回购股份约390万股，已回购股份占公司总股本的比例为0.43%，成交的最高价为22.18元/股，最低价为15.11元/股，已支付的总金额约为6999万元。2023年1至12月份，九洲药业的营业收入构成为：化学原料药及中间体的生产及销售占比97.87%。截至发稿，九洲药业市值为149亿元。文章来源：每日经济新闻原标题：九洲药业：累计回购约390万股","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050617193587d7f28c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050617193587d7f28c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433446985","title":"九洲药业(603456.SH)：累计回购389.53万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2433446985","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2433446985?lang=zh_cn&edition=full","pubTime":"2024-05-06 17:02","pubTimestamp":1714986141,"startTime":"0","endTime":"0","summary":"格隆汇5月6日丨九洲药业(603456.SH)公布，截止2024年4月30日，公司本次回购通过集中竞价交易方式累计回购股份3,895,300股，已回购股份占公司总股本的比例为0.43%，成交的最高价为22.18元/股，最低价为15.11元/股，已支付的总金额为69,993,558.10元（不含交易费用）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061702388b794791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061702388b794791&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433122034","title":"九洲药业05月06日遭主力抛售1279万元 环比增加211.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433122034","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433122034?lang=zh_cn&edition=full","pubTime":"2024-05-06 15:19","pubTimestamp":1714979941,"startTime":"0","endTime":"0","summary":"05月06日, 九洲药业股价涨2.98%，报收16.60元，成交金额3.04亿元，换手率2.04%，振幅2.67%，量比0.88。九洲药业今日主力资金净流出1279万元，连续3日净流出，上一交易日主力净流出411万元，今日环比增加211.19%。该股近5个交易日上涨12.77%，主力资金累计净流入1213万元；近20日主力资金累计净流出4110万元，其中净流出天数为12日。净流出前三个股分别为泰格医药、新里程、九洲药业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061534208b78fcbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061534208b78fcbb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431706648","title":"九洲药业获融资买入0.34亿元，近三日累计买入0.86亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431706648","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431706648?lang=zh_cn&edition=full","pubTime":"2024-04-30 08:14","pubTimestamp":1714436056,"startTime":"0","endTime":"0","summary":"4月29日，沪深两融数据显示，九洲药业获融资买入额0.34亿元，居两市第385位，当日融资偿还额0.46亿元，净卖出1283.04万元。最近三个交易日，25日-29日，九洲药业分别获融资买入0.31亿元、0.21亿元、0.34亿元。融券方面，当日融券卖出1.28万股，净买入0.11万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043008143487c151de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043008143487c151de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431325044","title":"九洲药业4月26日获北向资金加仓255.20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431325044","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431325044?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:30","pubTimestamp":1714354232,"startTime":"0","endTime":"0","summary":"4月26日, 北向资金增持九洲药业255.20万股。截止当日收盘，沪股通共持有九洲药业1334.79万股，占流通股1.48%。沪股通增持金额前五个股分别为招商银行、贵州茅台、兴业银行、药明康德、三一重工。九洲药业近5个交易日上涨5.62%，沪股通累计增持258.44万股；近20个交易日下跌13.29%，沪股通累计增持124.90万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404290935558b5f9d10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404290935558b5f9d10&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-10-10","address":"浙江省台州市椒江区外沙路99号","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0968},{"period":"3month","weight":-0.1764},{"period":"6month","weight":-0.4116},{"period":"1year","weight":-0.4681},{"period":"ytd","weight":-0.3309}],"companyName":"浙江九洲药业股份有限公司","boardCode":"AI0027","perCapita":"21239股","boardName":"医药制造业","registeredCapital":"89948万元","compareEarnings":[{"period":"1week","weight":0.0073},{"period":"1month","weight":0.0345},{"period":"3month","weight":0.085},{"period":"6month","weight":0.0419},{"period":"1year","weight":-0.0342},{"period":"ytd","weight":0.066}],"survey":"　　浙江九洲药业股份有限公司主营业务为医药定制研发和生产（CDMO）服务，包含小分子化学药物、多肽药物、偶联药物和小核酸药物。公司产品涵盖合同定制类、抗感染类、中枢神经类药物、非甾体类药物、降血糖类药。公司获得中国医药工业百强企业、中国医药工业最具成长力企业、中国医药上市公司最具竞争力20强、第九届浙江省人民政府质量管理创新奖等多项荣誉。","serverTime":1716249487715,"listedPrice":15.43,"stockholders":"42285人(较上一季度增加9.45%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九洲药业(603456)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九洲药业,603456,九洲药业股票,九洲药业股票老虎,九洲药业股票老虎国际,九洲药业行情,九洲药业股票行情,九洲药业股价,九洲药业股市,九洲药业股票价格,九洲药业股票交易,九洲药业股票购买,九洲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九洲药业(603456)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}